×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Cancer Supportive Care Market

ID: MRFR/HC/50017-HCR
200 Pages
Rahul Gotadki
February 2026

India Cancer Supportive Care Market Research Report By Type (ESA, G-CSFs, Antiemetics, Bisphosphonates, Opioids, NSAIDs, Others), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Others) and By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, Online Providers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Cancer Supportive Care Market Infographic
Purchase Options

India Cancer Supportive Care Market Summary

As per Market Research Future analysis, the India cancer supportive care market size was estimated at 1045.5 USD Million in 2024. The India cancer supportive-care market is projected to grow from 1071.64 USD Million in 2025 to 1372.1 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 2% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India cancer supportive-care market is experiencing notable growth driven by evolving patient needs and technological advancements.

  • The integration of palliative care into treatment plans is becoming increasingly prevalent in India.
  • Telehealth services are on the rise, enhancing access to supportive care for patients across the country.
  • There is a growing emphasis on mental health support as part of comprehensive cancer care strategies.
  • The increasing incidence of cancer and rising awareness of supportive care are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 1045.5 (USD Million)
2035 Market Size 1372.1 (USD Million)
CAGR (2025 - 2035) 2.5%

Major Players

Roche (CH), Bristol-Myers Squibb (US), Amgen (US), Merck & Co. (US), Novartis (CH), Pfizer (US), Eli Lilly and Company (US), AstraZeneca (GB)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Cancer Supportive Care Market Trends

The cancer supportive-care market is experiencing notable growth, driven by an increasing awareness of the importance of holistic treatment approaches for cancer patients. This market encompasses a range of services and products designed to alleviate the physical and emotional burdens associated with cancer treatment. As the healthcare landscape evolves, there is a growing recognition of the need for supportive care that complements traditional therapies. This shift is influenced by a rising incidence of cancer cases, which necessitates comprehensive care strategies that address not only the disease but also the quality of life of patients. In recent years, the emphasis on patient-centered care has intensified, leading to the development of innovative solutions within the cancer supportive-care market. Various stakeholders, including healthcare providers and policymakers, are increasingly focusing on integrating supportive services into standard cancer treatment protocols. This integration aims to enhance patient outcomes and satisfaction, reflecting a broader trend towards personalized medicine. Furthermore, the availability of educational resources and support networks is expanding, empowering patients and their families to navigate the complexities of cancer care more effectively. As the market continues to evolve, it appears poised for further advancements that prioritize the well-being of individuals facing cancer.

Integration of Palliative Care

There is a growing trend towards the integration of palliative care within the cancer supportive-care market. This approach emphasizes the importance of managing symptoms and improving the quality of life for patients. Healthcare providers are increasingly recognizing that palliative care can be beneficial at any stage of cancer treatment, not just in end-of-life scenarios. This shift is likely to enhance patient experiences and outcomes.

Rise of Telehealth Services

The cancer supportive-care market is witnessing a rise in telehealth services, which offer patients convenient access to care and support. This trend is particularly relevant in the context of ongoing advancements in technology, enabling healthcare professionals to provide consultations and follow-ups remotely. Telehealth may improve accessibility for patients, especially those in rural areas, thereby expanding the reach of supportive care.

Focus on Mental Health Support

There is an increasing focus on mental health support within the cancer supportive-care market. Recognizing the psychological impact of a cancer diagnosis, healthcare providers are incorporating mental health services into treatment plans. This trend reflects a broader understanding of the need for comprehensive care that addresses both physical and emotional well-being, potentially leading to improved patient satisfaction and outcomes.

India Cancer Supportive Care Market Drivers

Increasing Cancer Incidence

The rising incidence of cancer in India is a primary driver for the cancer supportive-care market. According to the National Cancer Registry Programme, the number of new cancer cases is projected to reach 1.5 million by 2025. This alarming trend necessitates enhanced supportive care services to manage symptoms and improve the quality of life for patients. As the population ages and lifestyle factors contribute to higher cancer rates, the demand for supportive care services is expected to grow significantly. This growth is likely to stimulate investments in the cancer supportive-care market, leading to the development of innovative therapies and services tailored to patient needs. Consequently, healthcare providers are increasingly focusing on integrating supportive care into standard cancer treatment protocols, thereby expanding the market's scope and reach.

Government Initiatives and Funding

Government initiatives aimed at improving cancer care in India are significantly influencing the cancer supportive-care market. The National Health Mission and various state-level programs are designed to enhance cancer treatment accessibility and affordability. Increased funding for cancer research and supportive care services is expected to bolster the market. For instance, the government has allocated substantial budgets for cancer control programs, which include palliative care and psychological support services. This financial backing is likely to encourage healthcare providers to expand their offerings in the cancer supportive-care market, ensuring that patients receive comprehensive care throughout their treatment journey. Furthermore, public awareness campaigns are being launched to educate patients and families about the importance of supportive care, which may lead to increased utilization of these services.

Growth of Home-Based Care Services

The growth of home-based care services is emerging as a significant driver for the cancer supportive-care market in India. Many patients prefer receiving care in the comfort of their homes, especially during advanced stages of cancer. This preference is prompting healthcare providers to develop and offer home-based supportive care services, including pain management, nutritional support, and psychological counseling. The convenience and personalized nature of home care are appealing to patients and their families, potentially leading to better adherence to treatment plans. As the demand for home-based services increases, the cancer supportive-care market is likely to expand, with providers investing in training and resources to deliver high-quality care in home settings.

Rising Awareness of Supportive Care

There is a growing awareness of the importance of supportive care among patients, families, and healthcare providers in India. This heightened awareness is driving demand for services that address the physical, emotional, and psychological needs of cancer patients. Educational initiatives and advocacy groups are playing a pivotal role in promoting the benefits of supportive care, which is likely to lead to increased patient engagement in their treatment plans. As more patients recognize the value of supportive care, healthcare providers are responding by expanding their offerings in the cancer supportive-care market. This trend may result in a more holistic approach to cancer treatment, where supportive care is viewed as an integral component of the overall care continuum.

Technological Advancements in Treatment

Technological advancements in cancer treatment are driving the growth of the cancer supportive-care market in India. Innovations such as targeted therapies, immunotherapy, and personalized medicine are becoming more prevalent, necessitating corresponding supportive care strategies. As treatment modalities evolve, patients often experience complex side effects that require specialized supportive care. The integration of technology in monitoring patient health and managing symptoms is becoming increasingly important. For example, wearable devices and mobile applications are being utilized to track patient progress and provide real-time support. This trend indicates a shift towards a more patient-centered approach in the cancer supportive-care market, where technology plays a crucial role in enhancing patient outcomes and satisfaction.

Market Segment Insights

By Type: ESA (Largest) vs. G-CSFs (Fastest-Growing)

In the India cancer supportive-care market, the segment values demonstrate a varied market share distribution among different categories. Erythropoiesis-Stimulating Agents (ESA) hold the largest share, significantly influencing treatment protocols by addressing anemia in cancer patients. Following ESA, Granulocyte Colony-Stimulating Factors (G-CSFs) also hold a substantial position, playing a crucial role in managing chemotherapy-induced neutropenia, thus contributing to their growth in the market. Recent trends indicate a robust growth trajectory for G-CSFs, driven by increasing cancer incidences and the rising necessity for supportive therapies that alleviate treatment-related side effects. Factors such as enhanced awareness about cancer treatment, favorable government initiatives, and the expansion of oncology-focused healthcare services are propelling the growth of these segments, indicating a shift towards more comprehensive care solutions for cancer patients in India.

ESA (Dominant) vs. Opioids (Emerging)

Erythropoiesis-Stimulating Agents (ESA) are recognized as the dominant force in the India cancer supportive-care market, primarily due to their effectiveness in managing anemia associated with chemotherapy. They are frequently prescribed to improve the quality of life for patients undergoing cancer treatment by alleviating fatigue and enhancing energy levels. In contrast, Opioids represent an emerging segment, gaining traction as they address pain management needs effectively. The rise in opioid prescriptions is attributed to the growing recognition of pain as a critical aspect of cancer care. While ESA remains foundational to supportive care, Opioids are increasingly positioned to fill the gaps in pain relief, demonstrating the evolving landscape of supportive treatments in oncology.

By Application: Breast Cancer (Largest) vs. Lung Cancer (Fastest-Growing)

In the India cancer supportive-care market, the application segment is significantly dominated by breast cancer treatment, which accounts for the largest share among all cancer types. This predominant position is supported by the high incidence rate of breast cancer in the country, leading to increased demand for supportive care solutions. Lung cancer, on the other hand, is witnessing rapid growth, reflecting changing lifestyles and increased tobacco consumption, contributing to its rising prevalence. The growth trends in this segment are largely driven by innovations in supportive care therapies and an increased focus on patient-centric care. Additionally, rising awareness regarding cancer management and the importance of supportive therapies for improving quality of life among cancer patients are key factors contributing to the growth of both the breast and lung cancer applications. The emergence of advanced treatment protocols and personalized medicine is further propelling market dynamics, making lung cancer one of the fastest-growing segments in this space.

Breast Cancer (Dominant) vs. Lung Cancer (Emerging)

Breast cancer remains the dominant application in the India cancer supportive-care market, leading the charge with its extensive treatment options and well-established support systems. This includes a range of therapies focused on alleviating symptoms, improving overall wellness, and enhancing life quality. With a robust framework in place, breast cancer care is continually evolving, embracing the latest research and technology to refine approaches. In contrast, lung cancer is classified as an emerging application, exhibiting a swift increase in demand for supportive measures. This shift is fueled by the rising incidence rates and a greater emphasis on addressing the unique challenges faced by lung cancer patients. The need for tailored supportive care solutions is more pronounced, as healthcare providers aim to better manage the complexities associated with lung cancer.

By Distribution Channel: Hospital Pharmacies (Largest) vs. Online Providers (Fastest-Growing)

In the distribution channel segment of the India cancer supportive-care market, hospital pharmacies hold the largest market share, catering to a significant number of patients seeking immediate access to medications during their treatment at healthcare facilities. Following closely are drug stores and retail pharmacies, which also contribute to a considerable portion of the market, leveraging their wide network and community presence to serve patients. Online providers have emerged as a growing alternative, offering convenience and accessibility, especially in a fast-evolving digital landscape. The growth trends in this segment are driven by various factors, including the increasing number of cancer patients and the subsequent rise in demand for supportive care medications. The shift towards online services has accelerated due to advances in technology and changing consumer preferences for home delivery and telemedicine. Furthermore, hospital pharmacies continue to dominate as they are preferred for immediate care, whereas online providers are poised for rapid growth, appealing to tech-savvy consumers looking for convenience and transparency in pricing.

Hospital Pharmacies (Dominant) vs. Online Providers (Emerging)

Hospital pharmacies play a critical role in the India cancer supportive-care market, primarily due to their integrated services within healthcare institutions that offer immediate access to necessary medications. Their dominance stems from the trust and reliability associated with hospital settings, ensuring that patients receive essential therapies as part of their treatment plan. In contrast, online providers are emerging strongly, capitalizing on the growing trend of digital healthcare solutions. They provide a diverse array of supportive care products accessible from the comfort of home, appealing particularly to younger, tech-savvy populations who prioritize convenience. This shift towards online platforms indicates a changing landscape, with patients increasingly willing to explore alternative purchasing options for their medications.

Get more detailed insights about India Cancer Supportive Care Market

Key Players and Competitive Insights

The cancer supportive-care market in India is characterized by a dynamic competitive landscape, driven by increasing cancer prevalence and a growing emphasis on patient-centric care. Major players such as Roche (CH), Bristol-Myers Squibb (US), and Amgen (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Roche (CH) focuses on integrating advanced diagnostics with therapeutic solutions, while Bristol-Myers Squibb (US) emphasizes immunotherapy advancements. Amgen (US) is actively pursuing collaborations to expand its portfolio in supportive care, indicating a collective shift towards comprehensive treatment approaches that address both the disease and the quality of life for patients.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure appears moderately fragmented, with several players vying for market share. However, the influence of key players is substantial, as they drive innovation and set industry standards, thereby shaping the overall market dynamics.

In October Roche (CH) announced a partnership with a leading Indian healthcare provider to enhance access to its supportive care therapies across rural regions. This strategic move is likely to improve patient access to essential treatments, thereby reinforcing Roche's commitment to patient-centric care and expanding its footprint in underserved markets. Such initiatives may also foster brand loyalty and enhance the company's reputation in the region.

In September Bristol-Myers Squibb (US) launched a new patient support program aimed at improving adherence to treatment regimens among cancer patients. This initiative underscores the company's focus on enhancing patient outcomes through education and support, which could potentially lead to increased market share as patients and healthcare providers recognize the value of comprehensive care solutions.

In August Amgen (US) entered into a collaboration with a local biotechnology firm to develop novel supportive care therapies tailored to the Indian population. This partnership not only signifies Amgen's commitment to innovation but also highlights the importance of localized solutions in addressing specific patient needs, which may enhance its competitive edge in the market.

As of November current trends in the cancer supportive-care market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on innovation and technology rather than solely on price. The focus on supply chain reliability and patient-centric solutions will likely define the future trajectory of the market.

Key Companies in the India Cancer Supportive Care Market include

Industry Developments

The India Cancer Supportive Care Market has recently witnessed significant developments, particularly with hospitals enhancing their supportive care services. The Rajasthan Cancer Institute has successfully expanded its services to encompass advanced palliative care programs, effectively addressing patient needs during and post-treatment. Manipal Hospitals and Apollo Hospitals Enterprise are actively adopting new technologies and treatment approaches to provide better supportive care, emphasizing personalized treatments. A notable acquisition was made in August 2023 when HCG Oncology acquired a specialized pain management clinic, further broadening its reach in supportive care. 

The Tata Memorial Centre continues to pave the way in Research and Development, focusing on innovative interventions to improve the quality of life for cancer patients. In addition, Dr. Lal PathLabs has initiated collaborations aimed at comprehensive patient support and enhanced diagnostic services. The growth prospects within the India Cancer Supportive Care Market are fueled by increasing cancer prevalence, which is projected to reach 1.57 million new cases in 2023, according to government health reports.

Companies like Fortis Healthcare and Narayana Health are expanding their cancer services, reflecting a concerted effort towards comprehensive care and treatment modalities over the past couple of years.

Future Outlook

India Cancer Supportive Care Market Future Outlook

The Cancer Supportive Care Market in India is projected to grow at 2.5% CAGR from 2025 to 2035, driven by increasing patient needs and advancements in treatment options.

New opportunities lie in:

  • Development of telehealth platforms for remote patient monitoring
  • Expansion of personalized nutrition programs for cancer patients
  • Investment in AI-driven predictive analytics for treatment optimization

By 2035, the market is expected to achieve substantial growth, reflecting evolving patient care dynamics.

Market Segmentation

India Cancer Supportive Care Market Type Outlook

  • ESA (Erythropoiesis-Stimulating Agents)
  • G-CSFs (Granulocyte Colony-Stimulating Factors)
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
  • Others

India Cancer Supportive Care Market Application Outlook

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Stomach Cancer
  • Others

India Cancer Supportive Care Market Distribution Channel Outlook

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

Report Scope

MARKET SIZE 2024 1045.5(USD Million)
MARKET SIZE 2025 1071.64(USD Million)
MARKET SIZE 2035 1372.1(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 2.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Roche (CH), Bristol-Myers Squibb (US), Amgen (US), Merck & Co. (US), Novartis (CH), Pfizer (US), Eli Lilly and Company (US), AstraZeneca (GB)
Segments Covered Type, Application, Distribution Channel
Key Market Opportunities Integration of telehealth solutions enhances access to cancer supportive-care services in evolving healthcare landscape.
Key Market Dynamics Rising demand for personalized therapies drives innovation in the cancer supportive-care market in India.
Countries Covered India
Leave a Comment

FAQs

What is the expected market size of the India Cancer Supportive Care Market in 2024?

The India Cancer Supportive Care Market is anticipated to be valued at 1.05 billion USD in 2024.

What will be the market size of the India Cancer Supportive Care Market by 2035?

By 2035, the India Cancer Supportive Care Market is projected to reach a value of 1.53 billion USD.

What is the expected CAGR for the India Cancer Supportive Care Market from 2025 to 2035?

The market is expected to grow at a CAGR of 3.522% from 2025 to 2035.

Which type of cancer supportive care is projected to have the highest market value in 2024?

In 2024, Erythropoiesis-Stimulating Agents (ESA) are projected to have the highest market value at 0.3 billion USD.

What is the market value of G-CSFs in 2024?

The market value of G-CSFs is expected to be 0.25 billion USD in 2024.

Who are the key players in the India Cancer Supportive Care Market?

Key players include Rajasthan Cancer Institute, Apollo Hospitals, HCG Oncology, and Tata Memorial Centre among others.

What is the anticipated market growth rate for bisphosphonates from 2024 to 2035?

The market for bisphosphonates is expected to grow from 0.15 billion USD in 2024 to 0.25 billion USD by 2035.

What regional dynamics could impact the growth of the India Cancer Supportive Care Market?

Urbanization and increasing healthcare access in regions across India will positively impact market growth.

What are some key challenges faced by the India Cancer Supportive Care Market?

Challenges include high treatment costs and limited patient awareness regarding supportive care options.

How will government initiatives influence the India Cancer Supportive Care Market?

Government initiatives aimed at improving cancer care and research funding will drive market growth significantly.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions